Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

July 25, 2019

Primary Completion Date

March 31, 2022

Study Completion Date

July 7, 2022

Conditions
Acromegaly
Interventions
DRUG

IONIS GHR-LRx

Participants will receive IONIS GHR-LRx by subcutaneous injection.

DRUG

Somatostatin Receptor Ligand (SRL)

Participants will receive Somatostatin Receptor Ligand (lanreotide, octreotide) once monthly.

Trial Locations (22)

1062

Magyar Honvedseg Allami Egeszsegugyi Kozpont, II. sz Belgyogyaszat Osztaly, Budapest

9112

Vaidoto Urbanaviciaus Individuali imone - Endokrinologijos klinika, Vilnius

10065

Memorial Sloan Kettering Cancer Center, New York

11000

Clinical Center of Serbia, Belgrade

35294

University of Alabama at Birmingham, Birmingham

44195

Cleveland Clinic, Cleveland

60208

Northwestern University, Evanston

89149

Palm Research Center, Inc., Las Vegas

97239

Oregon Health & Science University, Portland

117036

"Federal State Budget Institution National Medical Research Center of Endocrinology of the Ministry of Healthcare of the Russian Federation", Moscow

119991

I.M. Sechenov Moscow First State Medical University, Moscow

170036

State Budget Healthcare Institution of the Tver Region (Regional Clinical Hospital), Tver'

194156

Almazov National Medical Research Centre, Saint Petersburg

420101

Interregional Clinical Diagnostic Center, Kazan'

460018

Orenburg Regional Clinical Hospital, Orenburg

630087

Novosibirsk State Regional Clinical Hospital, Novosibirsk

650066

Kemerovo Regional Clinical Hospital n.a. S.V. Belyaev, Kemerovo

656043

Multi-field Medical Clinic Anturium LLC, Barnaul

LT-50161

Hospital of Lithuanian University of Health Sciences (LSMU) Kauno klinikos - Endocrinology clinic, Kaunas

31-011

"Centrum Nowoczesnych Terapii Dobry Lekarz Sp. z o. o.", Krakow

67-100

Twoja Przychodnia - Centrum Medyczne Nowa Sol, Nowa Sól

03-242

Mazowiecki Szpital Brodnowski, Warsaw

Sponsors
All Listed Sponsors
lead

Ionis Pharmaceuticals, Inc.

INDUSTRY